Financials and Corporate

Innate Pharma will hold its Annual General Meeting of Shareholders (“AGM”) on June 23, 2009, at 11 am in its headquarters, 117 avenue de Luminy, F-13009 Marseilles. The Notice of Meeting of this...

Reference Document includes Annual Report. The English version of the Reference Document is available. In order to download it, please click the thumbnail. Hard copies of these documents are available...

2.5 million euros in turnover in the first quarter ending March 31, 2009 35.4 million euros in cash and cash equivalent as at March 31, 2009 (excluding 4.4 million euros in research tax credit...

Innate Pharma announces today the strengthening of its management team with the appointment of Marcel Rozencweig, MD, as Senior Vice President in charge of clinical and regulatory strategy.

Innate Pharma announces it will participate to the following analyst and investor conferences in the coming weeks: BioCapital Europe, April 21, 2009, in Amsterdam, The Netherlands; C,F&B Smallcap...